Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek’s disease virus

Journal of Virological Methods - Tập 233 - Trang 23-36 - 2016
Susan J. Baigent1, Venugopal K. Nair1, Hervé Le Galludec2
1Avian Oncogenic Virus Group, The Pirbright Institute, Woking, GU24 0NF, United Kingdom
2Zoetis International Services, 23-25 Avenue du Docteur Lannelongue, 75668 Paris Cedex 14, France

Tài liệu tham khảo

Baigent, 2004, Marek’s disease virus: biology and life cycle, 62 Baigent, 2005, Absolute quantitation of Marek’s disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR, J. Virol. Methods, 23, 53, 10.1016/j.jviromet.2004.08.019 Baigent, 2005, Replication kinetics of Marek’s disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation, J. Gen. Virol., 86, 2989, 10.1099/vir.0.81299-0 Baigent, 2006, Vaccinal control of Marek’s disease: current challenges, and future strategies to maximize protection, Vet. Immunol. Immunopathol., 112, 78, 10.1016/j.vetimm.2006.03.014 Baigent, 2006, Real-time quantitative PCR for Marek’s disease vaccine virus in feather samples: applications and opportunities, vol. 126, 271 Baigent, 2007, Correlation of Marek’s disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model, Avian Pathol., 36, 467, 10.1080/03079450701639319 Baigent, 2011, Differential quantification of cloned CVI988 vaccine strain and virulent RB-1B strain of Marek’s disease viruses in chicken tissues using real-time PCR, Res. Vet. Sci., 91, 167, 10.1016/j.rvsc.2010.08.002 Baigent, 2013, Relationship between levels of very virulent MDV in poultry dust and in feather tips from vaccinated chickens, Avian Dis., 57, 440, 10.1637/10356-091012-Reg.1 Barrow, 1999, Molecular characteristics of very virulent European MDV isolates, Acta Virol., 43, 90 Becker, 1992, Polymerase chain reaction for differentiation between pathogenic and non-pathogenic serotype 1 Marek’s disease viruses (MDV) and vaccine viruses of MDV-serotypes 2 and 3, J. Virol. Methods, 40, 307, 10.1016/0166-0934(92)90089-V Calnek, 2001, Pathogenesis of Marek’s disease virus infection, vol. 255, 25 Chang, 2002, Diversity (polymorphism) of the meq gene in the attenuated Marek’s disease virus (MDV) serotype 1 and MDV-transformed cell lines, J. Vet. Med. Sci., 64, 1097, 10.1292/jvms.64.1097 Cui, 1991, Structural analysis and transcriptional mapping of the Marek’s disease virus gene encoding pp38, an antigen associated with transformed cells, J. Virol., 65, 6509, 10.1128/JVI.65.12.6509-6515.1991 Cui, 1999, Construction and characterisation of a H19 epitope point mutant of MDV CVI988/Rispens strain, Acta Virol., 43, 169 Davidson, 2002, Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens, J. Vet. Med., 49, 83, 10.1046/j.1439-0450.2002.00512.x Davison, 2005, Use of Marek’s disease vaccines: could they be driving the virus to increasing virulence?, Expert Rev. Vaccines, 4, 77, 10.1586/14760584.4.1.77 de Boer, 1986, Protective efficacy of Marek’s disease virus (MDV) CVI-988CEF65 clone C against challenge infection with three very virulent MDV strains, Avian Dis., 30, 276, 10.2307/1590529 Dunn, 2010, The effect of the time interval between exposures on the susceptibility of chickens to superinfection with Marek’s disease virus, Avian Dis., 54, 1038, 10.1637/9348-033010-Reg.1 Dunn, 2012, Competition between two virulent Marek’s disease virus strains in vivo, Avian Pathol., 41, 267, 10.1080/03079457.2012.677804 Endoh, 1994, Expression and purification of recombinant Marek’s disease virus serotype 1 specific phosphorylated protein pp38 in E. coli, J. Vet. Med. Sci, 56, 823, 10.1292/jvms.56.823 Gimeno, 2014, Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek’s disease viruses, Avian Dis., 58, 232, 10.1637/10666-091713-Reg.1 Gimeno, 2008, Marek’s disease vaccines: a solution for today but a worry for tomorrow?, Vaccine, 26, C31, 10.1016/j.vaccine.2008.04.009 Haq, 2012, Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek’s disease virus strain in feathers of chickens, Avian Pathol., 41, 69, 10.1080/03079457.2011.640304 Islam, 2004, Differential amplification and quantitation of Marek’s disease viruses using real-time polymerase chain reaction, J. Virol. Methods, 119, 103, 10.1016/j.jviromet.2004.03.006 Islam, 2006, Absolute quantitation of Marek’s disease virus and Herpesvirus of turkeys in chicken lymphocyte, feather tip and dust samples using real-time PCR, J. Virol. Methods, 132, 127, 10.1016/j.jviromet.2005.10.009 Islam, 2006, Relationship between Marek’s disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek’s disease in broiler chickens, Avian Pathol., 35, 42, 10.1080/03079450500465734 Islam, 2013, Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek’s disease virus challenge, Avian Pathol., 42, 516, 10.1080/03079457.2013.841312 Islam, 2014, Replication kinetics and shedding of very virulent Marek’s disease virus and vaccinal Rispens/CVI988 virus during single and mixed infections varying in order and interval between infections, Vet. Microbiol., 173, 208, 10.1016/j.vetmic.2014.07.027 King, 1981, Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek’s disease vaccines, Avian Dis., 25, 74, 10.2307/1589828 Landman, 2003, Titration of Marek’s disease cell-associated vaccine virus (CVI 988) of reconstituted vaccine and vaccine ampoules from Dutch hatcheries, Avian Dis., 47, 1458, 10.1637/7034 Lee, 2000, Difference in the meq gene between oncogenic and attenuated strains Marek’s disease virus serotype 1, J. Vet. Med. Sci., 62, 287, 10.1292/jvms.62.287 Lee, 2005, Characterization of a very virulent Marek’s disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens, Virus Genes, 31, 73, 10.1007/s11262-005-2202-2 Lee, 2012, Attenuated vaccines can recombine to form virulent field viruses, Science, 337, 188, 10.1126/science.1217134 Murata, 2007, Development of a nested polymerase chain reaction method to detect oncogenic Marek’s disease virus from feather tips, J. Vet. Diagn. Invest., 19, 471, 10.1177/104063870701900503 Niikura, 2006, Stability of Marek’s disease virus 132-bp repeats during serial in vitro passages, Arch. Virol., 151, 1431, 10.1007/s00705-006-0724-0 Okazaki, 1970, Protection against Marek’s disease by vaccination with a herpesvirus of turkeys, Avian Dis., 14, 413, 10.2307/1588488 Parker, 2006, Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan® real-time PCR, J. Clin. Microbiol., 44, 3911, 10.1128/JCM.00346-06 Petherbridge, 2003, Replication-competent bacterial artificial chromosomes of Marek’s disease virus: novel tools for generation of molecularly defined herpesvirus vaccines, J. Virol., 77, 8712, 10.1128/JVI.77.16.8712-8718.2003 Petherbridge, 2004, Oncogenicity of virulent Marek’s disease virus cloned as bacterial artificial chromosomes, J. Virol., 78, 13376, 10.1128/JVI.78.23.13376-13380.2004 Quinlivan, 2005, An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild-type strains of varicella-zoster virus, J. Med. Virol., 75, 174, 10.1002/jmv.20253 Read, 2015, Imperfect vaccination can enhance the transmission of highly virulent pathogens, PLoS Biol., 13, 10.1371/journal.pbio.1002198 Renz, 2006, Absolute quantification using real-time polymerase chain reaction of Marek’s disease virus serotype 2 in field dust samples, feather tips and spleens, J. Virol. Methods, 135, 186, 10.1016/j.jviromet.2006.03.017 Renz, 2013, Differentiation between pathogenic serotype 1 isolates of Marek’s disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis, J. Virol. Methods, 187, 144, 10.1016/j.jviromet.2012.09.018 Rispens, 1972, Control of marek’s disease in the Netherlands. I. Isolation of an avirulent Marek’s disease virus (strain CVI 988) and its use in laboratory vaccination trials, Avian Dis., 16, 108, 10.2307/1588905 Schat, 1978, Characterization of an apparently nononcogenic Marek’s disease virus, J. Natl. Cancer Inst., 60, 1075, 10.1093/jnci/60.5.1075 Schat, 1982, Characterisation of two highly oncogenic strains of Marek’s disease virus, Avian Pathol., 11, 593, 10.1080/03079458208436134 Silva, 2007, Oncogenic Marek’s disease viruses lacking the 132 base pair repeats can still be attenuated by serial in vitro cell culture passages, Virus Genes, 34, 87, 10.1007/s11262-006-0022-7 Silva, 1992, Differentiation of pathogenic and non-pathogenic serotype 1 Marek’s disease viruses (MDVs) by the polymerase chain reaction amplification of the tandem direct repeats within the MDV genome, Avian Dis., 36, 521, 10.2307/1591744 Singh, 2010, Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek’s disease virus, Res. Vet. Sci., 89, 140, 10.1016/j.rvsc.2010.01.010 Smith, 2011, Pathogenicity of a very virulent strain of Marek’s disease herpesvirus cloned as infectious bacterial artificial chromosomes, J. Biomed. Biotechnol., 412829 Spatz, 2007, Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek’s disease virus 1, Virus Genes, 35, 41, 10.1007/s11262-006-0024-5 Spatz, 2007, Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek’s disease virus, J. Gen. Virol., 88, 1080, 10.1099/vir.0.82600-0 Spatz, 2007, Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek’s disease virus, Virus Genes, 35, 753, 10.1007/s11262-007-0157-1 Walkden-Brown, 2013, Pathotyping of Australian isolates of Marek’s disease virus in commercial broiler chickens vaccinated with herpesvirus of turkeys (HVT) or bivalent (HVT/SB1) vaccine and association with viral load in the spleen and feather dander, Aust. Vet. J, 91, 341, 10.1111/avj.12084 Walkden-Brown, 2013, Development, application and results of routine monitoring of Marek’s disease virus in broiler house dust using real time quantitative PCR, Avian Dis., 57, 544, 10.1637/10380-92112-REG.1 Witter, 1997, Increased virulence of Marek’s disease virus field isolates, Avian Dis., 41, 149, 10.2307/1592455 Witter, 2005, Classification of Marek’s disease viruses according to pathotype: philosophy and methodology, Avian Pathol., 34, 75, 10.1080/03079450500059255 Zhizhong, 2004, Analyzing the H19- and T65-epitopes in 38 kd phosphorylated protein of Marek’s disease viruses and comparing chicken immunological reactions to viruses point-mutated in the epitopes, Sci. China C Life Sci., 47, 82, 10.1360/02yc0173 van Iddekinge, 1999, Genome analysis of Marek’s disease virus strain CVI-988: effect of cell culture passage on the inverted repeat regions, Avian Dis., 43, 182, 10.2307/1592607